stoxline Quote Chart Rank Option Currency Glossary
  
Augmedix, Inc. (AUGX)
4.09  0.05 (1.24%)    03-28 16:00
Open: 4.04
High: 4.16
Volume: 227,982
  
Pre. Close: 4.04
Low: 3.93
Market Cap: 195(M)
Technical analysis
2024-03-28 4:49:50 PM
Short term     
Mid term     
Targets 6-month :  5.4 1-year :  6.31
Resists First :  4.63 Second :  5.4
Pivot price 3.74
Supports First :  3.72 Second :  3.16
MAs MA(5) :  4 MA(20) :  3.84
MA(100) :  4.83 MA(250) :  4.46
MACD MACD :  -0.1 Signal :  -0.2
%K %D K(14,3) :  71.2 D(3) :  67.3
RSI RSI(14): 51.6
52-week High :  6.25 Low :  1.5
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ AUGX ] has closed below upper band by 24.0%. Bollinger Bands are 19.4% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 4.17 - 4.18 4.18 - 4.2
Low: 3.89 - 3.91 3.91 - 3.92
Close: 4.06 - 4.09 4.09 - 4.12
Company Description

Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live and Augmedix Notes solutions that provide pre-visit documentation, such as pre-charting and digitization of previous records/patient history; during-visit documentation, including medical notes, care gap reminders, HCC reminders, and after-visit summaries; and post-visit documentation consisting of coding, orders, and referrals. The company enables clinicians to access its applications through mobile devices, such as smartphones or Google Glass. It serves health systems and specialty groups. The company was founded in 2013 and is headquartered in San Francisco, California.

Headline News

Thu, 28 Mar 2024
Citigroup Inc. Takes $241000 Position in Augmedix, Inc. (NASDAQ:AUGX) - Defense World

Wed, 27 Mar 2024
Portside Wealth Group LLC Sells 35051 Shares of Augmedix, Inc. (NASDAQ:AUGX) - Defense World

Tue, 26 Mar 2024
Augmedix (OTCMKTS:AUGX) Trading 1% Higher - MarketBeat

Tue, 26 Mar 2024
Augmedix (OTCMKTS:AUGX) Trading Up 1% - Defense World

Sun, 24 Mar 2024
Augmedix: Secular AI Tailwinds, But Still Unattractive Risk-Reward (NASDAQ:AUGX) - Seeking Alpha

Sat, 23 Mar 2024
Augmedix, Inc. Revenue Breakdown – NASDAQ:AUGX – TradingView - TradingView

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Healthcare - Information Services
Shares Out 49 (M)
Shares Float 29 (M)
Held by Insiders 10.8 (%)
Held by Institutions 78.6 (%)
Shares Short 718 (K)
Shares Short P.Month 922 (K)
Stock Financials
EPS -0.5
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0.47
Profit Margin -42.8 %
Operating Margin -34.3 %
Return on Assets (ttm) -23.4 %
Return on Equity (ttm) -154.7 %
Qtrly Rev. Growth 44.9 %
Gross Profit (p.s.) 0
Sales Per Share 0.92
EBITDA (p.s.) -0.37
Qtrly Earnings Growth 0 %
Operating Cash Flow -15 (M)
Levered Free Cash Flow -9 (M)
Stock Valuations
PE Ratio -8.19
PEG Ratio 0
Price to Book value 8.52
Price to Sales 4.42
Price to Cash Flow -12.9
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android